| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10595605 | Bioorganic & Medicinal Chemistry Letters | 2009 | 4 Pages |
Abstract
A series of thieno[3,2-b]pyridine inhibitors of the receptor tyrosine kinases c-Met and VEGRF2, bearing the N3-arylmalonamides functionality, is described.
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Oscar Saavedra, Stephen Claridge, Lijie Zhan, Franck Raeppel, Marie-Claude Granger, Stéphane Raeppel, Michael Mannion, Frédéric Gaudette, Nancy Zhou, Ljubomir Isakovic, Naomy Bernstein, Robert Déziel, Hannah Nguyen, Normand Beaulieu, Carole Beaulieu,
![First Page Preview: N3-Arylmalonamides: A new series of thieno[3,2-b]pyridine based inhibitors of c-Met and VEGFR2 tyrosine kinases N3-Arylmalonamides: A new series of thieno[3,2-b]pyridine based inhibitors of c-Met and VEGFR2 tyrosine kinases](/preview/png/10595605.png)